FSA Wealth Management LLC Invests $65,000 in iShares Biotechnology ETF (NASDAQ:IBB)

FSA Wealth Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 447 shares of the financial services provider’s stock, valued at approximately $65,000.

A number of other large investors have also added to or reduced their stakes in the stock. Comerica Bank increased its holdings in iShares Biotechnology ETF by 6.7% in the 1st quarter. Comerica Bank now owns 18,629 shares of the financial services provider’s stock valued at $2,556,000 after buying an additional 1,169 shares during the period. Cetera Investment Advisers increased its stake in iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock valued at $12,498,000 after acquiring an additional 79,541 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its position in iShares Biotechnology ETF by 422.7% during the second quarter. Massmutual Trust Co. FSB ADV now owns 1,892 shares of the financial services provider’s stock valued at $260,000 after purchasing an additional 1,530 shares in the last quarter. Mather Group LLC. lifted its stake in iShares Biotechnology ETF by 125.3% during the second quarter. Mather Group LLC. now owns 953 shares of the financial services provider’s stock worth $131,000 after purchasing an additional 530 shares during the last quarter. Finally, Lynx Investment Advisory acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at $74,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $141.55 on Monday. iShares Biotechnology ETF has a 52 week low of $119.95 and a 52 week high of $150.57. The stock has a fifty day moving average of $142.71 and a 200-day moving average of $142.06.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.